GlassScriptPhysician profile
James J Brown
NPI 1013993716
$265.27
in general payments reported to CMS, 2019-2025
11 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12.82 · 2024: $62.35 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $43.63 | 2024-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $37.09 | 2025 | |
| Exact Sciences Corporation | $34.71 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $31.82 | 2024-2025 | Veozah |
| Edwards Lifesciences Corporation | $23.11 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Glaxosmithkline, LLC. | $22.10 | 2025 | Bexsero |
| Axsome Therapeutics, INC. | $17.34 | 2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $14.79 | 2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $14.18 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $13.68 | 2025 | Breztri |
| Pfizer INC. | $12.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.